Toward identification of the genetic risk profile for cryptococcal disease in HIV-infected patients

mBio

Volumn 4, Issue 5, 2013, Pages

  Netea, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELLULAR IMMUNITY; CRYPTOCOCCOSIS; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMORAL IMMUNITY; MORTALITY; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CRYPTOCOCCOSIS; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, IGG;

EID: 84887150909     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00798-13     Document Type: Article

References (14)

1. Chaturvedi V, Chaturvedi S. 2011. Cryptococcus gattii: a resurgent fungal pathogen. Trends Microbiol. 19:564-571.
2. Franzot SP, Salkin IF, Casadevall A. 1999. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J. Clin. Microbiol. 37:838-840.
3. Chayakulkeeree M, Perfect JR. 2006. Cryptococcosis. Infect. Dis. Clin. North Am. 20:507-544.
4. Sørensen TI, Nielsen GG, Andersen PK, Teasdale TW. 1988. Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med. 318:727-732.
5. Meletiadis J, Walsh TJ, Choi EH, Pappas PG, Ennis D, Douglas J, Pankey GA, Larsen RA, Hamill RJ, Chanock S. 2007. Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients. Med. Mycol. 45: 513-518.
6. Hu XP, Wu JQ, Zhu LP, Wang X, Xu B, Wang RY, Ou XT, Weng XH. 2012. Association of Fcgamma receptor IIB polymorphism with cryptococcal meningitis in HIV-uninfected Chinese patients. PLoS One 7:e42439. doi:10.1371/journal.pone.0042439.
7. Ou XT, Wu JQ, Zhu LP, Guan M, Xu B, Hu XP, Wang X, Weng XH. 2011. Genotypes coding for mannose-binding lectin deficiency correlated with cryptococcal meningitis in HIV-uninfected Chinese patients. J. Infect. Dis. 203:1686-1691.
8. Rohatgi S, Gohil S, Kuniholm MH, Schultz H, Dufaud C, Armour KL, Badri S, Mailliard RB, Pirofski L. 2013. Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease. mBio 4(5): e00573-13. doi:10.1128/mBio.00573-13.
9. Subramaniam K, Metzger B, Hanau LH, Guh A, Rucker L, Badri S, Pirofski LA. 2009. IgM() memory B cell expression predicts HIV-associated cryptococcosis status. J. Infect. Dis. 200:244-251.
10. Rohatgi S, Pirofski LA. 2012. Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection. J. Immunol. 189:5820-5830.
11. Szymczak WA, Davis MJ, Lundy SK, Dufaud C, Olszewski M, Pirofski LA. 2013. X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans infection. mBio 4(4):e00265-13. doi:10.1128/ mBio.00265-13.
12. Mukherjee J, Scharff MD, Casadevall A. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60: 4534-4541.
13. Mukherjee J, Pirofski LA, Scharff MD, Casadevall A. 1993. Antibodymediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc. Natl. Acad. Sci. U. S. A. 90:3636-3640.
14. Dromer F, Charreire J, Contrepois A, Carbon C, Yeni P. 1987. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect. Immun. 55:749-752.